Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies

INTRODUCTION: A post hoc, descriptive analysis of three prospective, randomised, controlled clinical studies investigating cefiderocol in gram-negative bacterial infections was conducted to assess its efficacy in patients with baseline bacteraemia. METHODS: Data from APEKS-cUTI (NCT02321800), APEKS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterson, David L., Kinoshita, Masahiro, Baba, Takamichi, Echols, Roger, Portsmouth, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960491/
https://www.ncbi.nlm.nih.gov/pubmed/35184255
http://dx.doi.org/10.1007/s40121-022-00598-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960491/
https://www.ncbi.nlm.nih.gov/pubmed/35184255
http://dx.doi.org/10.1007/s40121-022-00598-9

Ejemplares similares